162 related articles for article (PubMed ID: 1590275)
1. 131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma.
Hutchinson RJ; Sisson JC; Shapiro B; Miser JS; Normole D; Shulkin BL; Francis IR; Zasadny K; Carey JE; Johnson JW
Am J Clin Oncol; 1992 Jun; 15(3):226-32. PubMed ID: 1590275
[TBL] [Abstract][Full Text] [Related]
2. Survival of patients with neuroblastoma treated with 125-I MIBG.
Sisson JC; Shapiro B; Hutchinson RJ; Shulkin BL; Zempel S
Am J Clin Oncol; 1996 Apr; 19(2):144-8. PubMed ID: 8610638
[TBL] [Abstract][Full Text] [Related]
3. [131I]MIBG as a first line treatment in advanced neuroblastoma.
Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
[TBL] [Abstract][Full Text] [Related]
4. [131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.
Klingebiel T; Treuner J; Ehninger G; Keller KD; Dopfer R; Feine U; Niethammer D
Cancer Chemother Pharmacol; 1989; 25(2):143-8. PubMed ID: 2598401
[TBL] [Abstract][Full Text] [Related]
5. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma.
Hutchinson RJ; Sisson JC; Miser JS; Zasadny KR; Normolle DP; Shulkin BL; Francis IR; Wieland DM; Shapiro B
J Nucl Biol Med (1991); 1991; 35(4):237-40. PubMed ID: 1823826
[TBL] [Abstract][Full Text] [Related]
8. Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial.
Klingebiel T; Berthold F; Treuner J; Schwabe D; Fischer M; Feine U; Maul FD; Waters W; Wehinger H; Niethammer D
Med Pediatr Oncol; 1991; 19(2):84-8. PubMed ID: 2011100
[TBL] [Abstract][Full Text] [Related]
9. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
10. [Initial experiences in the treatment of children with metastatic and recurrent neuroblastoma using meta-iodobenzylguanidine].
Klingebiel T; Feine U; Niethammer D; Müller-Schauenburg W; Schwabe D; Maul FD; Gerein V; Fischer M; Gahr M; Kraz K
Klin Padiatr; 1986; 198(3):230-6. PubMed ID: 3723987
[TBL] [Abstract][Full Text] [Related]
11. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.
De Kraker J; Hoefnagel CA; Caron H; Valdés Olmos RA; Zsiros J; Heij HA; Voûte PA
Eur J Cancer; 1995; 31A(4):600-2. PubMed ID: 7576977
[TBL] [Abstract][Full Text] [Related]
12. Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.
Sisson JC; Shapiro B; Hutchinson RJ; Zasadny KR; Mallette S; Mudgett EE; Wieland DM
J Nucl Biol Med (1991); 1991; 35(4):255-9. PubMed ID: 1823830
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation.
Lashford LS; Lewis IJ; Fielding SL; Flower MA; Meller S; Kemshead JT; Ackery D
J Clin Oncol; 1992 Dec; 10(12):1889-96. PubMed ID: 1453204
[TBL] [Abstract][Full Text] [Related]
14. Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine.
Sisson JC; Shapiro B; Hutchinson RJ; Carey JE; Zasadny KR; Zempel SA; Normolle DP
Eur J Nucl Med; 1994 Jan; 21(1):46-52. PubMed ID: 8088285
[TBL] [Abstract][Full Text] [Related]
15. Critical observations on neuroblastoma treatment with 131-I-metaiodobenzylguanidine at diagnosis.
Mastrangelo R; Lasorella A; Iavarone A; Rufini V; Troncone L; Danza F; Riccardi R
Med Pediatr Oncol; 1993; 21(6):411-5. PubMed ID: 8515721
[TBL] [Abstract][Full Text] [Related]
16. Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG).
Zhou MJ; Doral MY; DuBois SG; Villablanca JG; Yanik GA; Matthay KK
Eur J Cancer; 2015 Nov; 51(16):2465-72. PubMed ID: 26254811
[TBL] [Abstract][Full Text] [Related]
17. 131I-metaiodobenzylguanidine in the treatment of neuroblastoma at diagnosis.
Mastrangelo R; Troncone L; Lasorella A; Riccardi R; Montemaggi P; Rufini V
Am J Pediatr Hematol Oncol; 1989; 11(1):28-31. PubMed ID: 2785352
[TBL] [Abstract][Full Text] [Related]
18. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.
Voûte PA; Hoefnagel CA; de Kraker J; Valdes Olmos R; Bakker DJ; van de Kleij AJ
Prog Clin Biol Res; 1991; 366():439-45. PubMed ID: 2068157
[No Abstract] [Full Text] [Related]
19. Treatment of neuroblastoma with 131I-MIBG: dosimetric problems and perspectives.
Beierwaltes WH
Med Pediatr Oncol; 1987; 15(4):188-91. PubMed ID: 3657705
[TBL] [Abstract][Full Text] [Related]
20. Iodine-125-MIBG to treat neuroblastoma: preliminary report.
Sisson JC; Hutchinson RJ; Shapiro B; Zasadny KR; Normolle D; Wieland DM; Wahl RL; Singer DA; Mallette SA; Mudgett EE
J Nucl Med; 1990 Sep; 31(9):1479-85. PubMed ID: 2395016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
